No published results from the one Phase II trial that was actually conducted
Consequently, we do not issue any form of licence, certificate or authorisation to aid personal importation
Join 1M+ subscribers to get regular emails on neuroscience, health, and science-related tools from Dr
It should also provide a thorough initial intake consultation as well as ongoing support during your treatment
Zhang Y, Yang X, Wang S, Song S (2019) Ginsenoside Rg3 prevents cognitive impairment by improving mitochondrial dysfunction in the rat model of Alzheimers disease
Journal of Clinical Medicine , 2021 Because of this, any long-term use beyond 68 weeks is based entirely on user experimentation and not medical data